既往治疗过的严重 B 型血友病的 I/II 期研究-猫眼课题宝

既往治疗过的严重 B 型血友病的 I/II 期研究

批准号：

6290962

负责人：

AMY SHAPIRO

金额：

$1.7万

依托单位：

INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS

依托单位国家：

美国

项目类别：

财政年份：

1998

资助国家：

美国

项目状态：

已结题

起止时间：

1998-12-01 至 1999-11-30

来源：

https://reporter.nih.gov/project-details/6290962

关键词：

blood disorder chemotherapy clinical research clinical trial phase I coagulation factor IX hemophilia B human subject human therapy evaluation pharmacokinetics recombinant proteins

项目摘要

项目成果

AMY SHAPIRO的其他基金

相似基金

相关文献

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

The primary objectives of the study are to assess the safety and efficacy of rhFIX in previously treated patients. Secondary objectives are to estimate the pharmacokinetic parameters, including recovery and half-life, of rhFIX administered as an intravenous infusion, to evaluate the pharmacokinetic parameters of rhFIX in comparison to pooled human plasma product Mononine to evaluate the efficacy and safety of rhFIX in treating acute bleeding episodes and to evaluate the efficacy and safety of rhFIX in controlling bleeding during and after surgical procedures.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文